Search

Displaying results 4111 - 4120 of 10000 in total
  1. Drug

    Tetradecylthioacetic acid

    go.drugbank.com/drugs/DB18802
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  2. Drug

    Dihydrolipoic Acid

    go.drugbank.com/drugs/DB03760
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Dodecyl sulfate

    go.drugbank.com/drugs/DB03967
    Investigational

    Synonyms: N-Dodecyl sulfateCategories: Compounds used in a research, industrial, or household setting
  4. Drug

    Lunacalcipol

    go.drugbank.com/drugs/DB05024
    Investigational

    secretion which may be involved in the etiology of psoriasis. … Preclinical studies have shown that CTA018 inhibits the proliferation of rapidly dividing cells such as human epidermal keratinocytes (skin cells) and is also effective in inhibiting pro-inflammatory cytokine

  5. Drug

    Gleptoferron

    go.drugbank.com/drugs/DB11417
    ExperimentalVet approved

    Colloid solution of ferric hydroxide, dextran & glucoheptonic acid.

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    4-dimethylaminophenol

    go.drugbank.com/drugs/DB13549
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    NOX-100

    go.drugbank.com/drugs/DB05799
    Investigational

    NOX-100 is the first in a series of proprietary NO neutralizing compounds Medinox is developing to bind and inactivate NO, a simple gas molecule that is a key biological messenger in the body. … NOX-100 is the new nitric oxide (NO) neutralizing agent being developed by San Diego-based Medinox -- demonstrated its effectiveness and potential as a therapeutic to treat hemorrhagic shock.

  8. Drug

    Enzastaurin

    go.drugbank.com/drugs/DB06486
    Investigational

    Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form of

  9. Drug

    DP-VPA

    go.drugbank.com/drugs/DB05821
    Investigational

    DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure

  10. Drug

    Rupintrivir

    go.drugbank.com/drugs/DB05102
    Experimental

    Rupintrivir was active against all 48 HRV serotypes tested in a cell protection assay in H1-HeLa cells. It is designed to combat colds caused by rhinovirus. … Rupintrivir is a rhinovirus 3C protease inhibitor in development for use against human rhinoviral (HRV) infections.